المؤلفون: Sjogren, E, Stahle, L, Quiding, H, Jonzon, B, Halldin, MM, Sundgren, AK

المصدر: European journal of pain (London, England). 23(10):1767-1779

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:141637194

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Makvandi K; Department of Molecular and Clinical Medicine/Nephrology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Hockings PD; Antaros Medical, Molndal, Sweden., Jensen G; Department of Molecular and Clinical Medicine/Nephrology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Unnerstall T; Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden., Leonhardt H; Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden., Jarl LV; Antaros Medical, Molndal, Sweden., Englund C; Antaros Medical, Molndal, Sweden., Francis S; Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, UK., Sundgren AK; Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Hulthe J; Antaros Medical, Molndal, Sweden., Baid-Agrawal S; Department of Molecular and Clinical Medicine/Nephrology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

المصدر: Clinical kidney journal [Clin Kidney J] 2022 Feb 24; Vol. 15 (7), pp. 1387-1402. Date of Electronic Publication: 2022 Feb 24 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101579321 Publication Model: eCollection Cited Medium: Print ISSN: 2048-8505 (Print) Linking ISSN: 20488505 NLM ISO Abbreviation: Clin Kidney J Subsets: PubMed not MEDLINE

المؤلفون: Bakker E; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Mol PGM; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, Netherlands.; Scientific Advice Working Party, European Medicines Agency (EMA), Amsterdam, Netherlands., Nabais J; Associação Protetora Dos Diabéticos de Portugal, Lisboa, Portugal.; Comprehensive Health Reserach Centre (CHRC), Departamento de Ciências Médicas e da Saúde, Escola de Saúde e Desenvolvimento Humano, Universidade de Évora, Évora, Portugal., Vetter T; European Medicines Agency (EMA), Amsterdam, Netherlands., Kretzler M; University of Michigan, Michigan Medicine, Internal Medicine/Nephrology and Computational Medicine and Bioinformatics, Ann Arbor, MI, United States., Nolan JJ; University of Dublin, Trinity College, Dublin, Ireland., Mayer G; Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria., Sundgren AK; AstraZeneca, Gaithersburg, MD, United States., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Schiel A; Scientific Advice Working Party, European Medicines Agency (EMA), Amsterdam, Netherlands.; Norwegian Medicines Agency, Oslo, Norway., de Vries ST; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Gomez MF; Department of Clinical Sciences, Lund University, Diabetes Centre, Malmö, Sweden., Schulze F; Boehringer Ingelheim International GmbH, Ingelheim, Germany., de Zeeuw D; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Pena MJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

مؤلفون مشاركون: BEAt-DKD Consortium

المصدر: Frontiers in pharmacology [Front Pharmacol] 2021 May 04; Vol. 12, pp. 662642. Date of Electronic Publication: 2021 May 04 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

المؤلفون: Mccafferty K; Department of Nephrology, Barts Health NHS Trust, London, UK., Caplin B; Centre for Nephrology, University College London Medical School, London, UK., Knight S; Department of Discovery Biology, Discovery Sciences, R&D, AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK., Hockings P; Antaros Medical, Gothenburg, Sweden.; MedTech West, Chalmers University of Technology, Goteborg, Sweden., Wheeler D; Centre for Nephrology, University College London Medical School, London, UK., Fan SL; Department of Nephrology, Barts Health NHS Trust, London, UK., Hulthe J; Antaros Medical, Gothenburg, Sweden., Kleta R; Divison of Medicine, University College London, London, UK., Ashman N; Department of Nephrology, Barts Health NHS Trust, London, UK., Papastefanou V; Barts Health NHS Trust, London, UK., Mehta H; Royal Free Hampstead NHS Trust, London, London, UK., Salama A; Divison of Medicine, University College London, London, UK., Hadzovic S; Department of BioPharma Early Biometrics and Statistical Innovation, AstraZeneca, Goteborg, Sweden., Chowdhury TA; Department of Diabetes and Metabolism, Barts Health NHS Trust, London, UK., Jarl L; Antaros Medical, Gothenburg, Sweden., Unwin R; Department of Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK., Challis B; Department of Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK., Sundgren AK; Department of Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.; Data Science & AI | BioPharma Early Biometrics and Statistical Innovation, AstraZeneca, Gothenburg, Sweden., Yaqoob MM; Department of Nephrology, Barts Health NHS Trust, London, UK m.m.yaqoob@qmul.ac.uk.

المصدر: BMJ open [BMJ Open] 2020 Sep 09; Vol. 10 (9), pp. e033923. Date of Electronic Publication: 2020 Sep 09.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Diabetic Nephropathies*/epidemiology, Cohort Studies ; Diabetes Mellitus, Type 1 ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Glomerular Filtration Rate ; Humans ; London/epidemiology